Customizable nanoparticles show potential for delivering personalized cancer vaccines
A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines. The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create…
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
